COVID-19 vaccination and the rate of immune and autoimmune adverse events following immunization: Insights from a narrative literature review

Basit Öğe Kaydı
dc.authorid0000-0002-7919-1326
dc.contributor.authorMahroum, Naim
dc.contributor.authorLavine, Noy
dc.contributor.authorOhayon, Aviran
dc.contributor.authorSeida, Ravend
dc.contributor.authorAlwani, Abdulkarim
dc.contributor.authorAlrais, Mahmoud
dc.contributor.authorZoubi, Magdi
dc.contributor.authorBragazzi, Nicola Luigi
dc.date.accessioned2022-07-29T06:38:33Z
dc.date.available2022-07-29T06:38:33Z
dc.date.issued2022
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstractDespite their proven efficacy and huge contribution to the health of humankind, vaccines continue to be a source of concern for some individuals around the world. Vaccinations against COVID-19 increased the number of distressed people and intensified their distrust, particularly as the pandemic was still emerging and the populations were encouraged to be vaccinated under various slogans like “back to normal life” and “stop coronavirus”, goals which are still to be achieved. As fear of vaccination-related adverse events following immunization (AEFIs) is the main reason for vaccine hesitancy, we reviewed immune and autoimmune AEFIs in particular, though very rare, as the most worrisome aspect of the vaccines. Among others, autoimmune AEFIs of the most commonly administered COVID-19 vaccines include neurological ones such as Guillain-Barre syndrome, transverse myelitis, and Bell’s palsy, as well as myocarditis. In addition, the newly introduced notion related to COVID-19 vaccines, “vaccine-induced immune thrombotic thrombocytopenia/vaccine-induced prothrombotic immune thrombotic thrombocytopenia” (VITT/VIPITT)”, is of importance as well. Overviewing recent medical literature while focusing on the major immune and autoimmune AEFIs, demonstrating their rate of occurrence, presenting the cases reported, and their link to the specific type of COVID-19 vaccines represented the main aim of our work. In this narrative review, we illustrate the different vaccine types in current use, their associated immune and autoimmune AEFIs, with a focus on the 3 main COVID-19 vaccines (BNT162b2, mRNA-1273, and ChAdOx1). While the rate of AEFIs is extremely low, addressing the issue in this manner, in our opinion, is the best strategy for coping with vaccine hesitancy.
dc.identifier.citationMahroum, N., Lavine, N., Ohayon, A., Seida, R., Alwani, A., Alrais, M. ... Bragazzi, N. L. (2022). COVID-19 vaccination and the rate of immune and autoimmune adverse events following immunization: Insights from a narrative literature review. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.872683
dc.identifier.doi10.3389/fimmu.2022.872683
dc.identifier.issn1664-3224
dc.identifier.pmid35865539
dc.identifier.scopus2-s2.0-85134231256
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.3389/fimmu.2022.872683
dc.identifier.urihttps://hdl.handle.net/20.500.12511/9618
dc.identifier.volume13
dc.identifier.wos000828770200001en_US
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorMahroum, Naim
dc.institutionauthorSeida, Ravend
dc.institutionauthorAlwani, Abdulkarim
dc.institutionauthorAlrais, Mahmoud
dc.language.isoen
dc.publisherFrontiers Media S.A.
dc.relation.ispartofFrontiers in Immunologyen_US
dc.relation.publicationcategoryDiğer
dc.rightsAttribution 4.0 International*
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectCOVID-19 Vaccine
dc.subjectVaccine Hesitancy
dc.subjectAutoimmune Side Effects
dc.subjectGuillain-Barre Syndrome
dc.subjectMyocarditis
dc.subjectVaccine-Induced Immune Thrombotic Thrombocytopenia
dc.titleCOVID-19 vaccination and the rate of immune and autoimmune adverse events following immunization: Insights from a narrative literature review
dc.typeReview Article

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Mahroum--Naim-2022.pdf
Boyut:
1.01 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Diğer Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu